Geninus Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 63

Employees

  • Stock Symbol
  • 389030

Stock Symbol

  • Share Price
  • $0.94
  • (As of Thursday Closing)

Geninus General Information

Description

Geninus Inc provides clinical genome analysis solutions for precision medicine clinics.

Contact Information

Website
geninustx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 70,Jeongui-ro
  • 4th-5thFloor(Munjeong-dong,KDU Tower)x
  • Songpa, Songpa-gu
  • South Korea
+82
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Stock Exchange
KRX
Corporate Office
  • 70,Jeongui-ro
  • 4th-5thFloor(Munjeong-dong,KDU Tower)x
  • Songpa, Songpa-gu
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geninus Stock Performance

As of 19-Nov-2026, Geninus’s stock price is $0.94. Its current market cap is $37.2M with 39.4M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.94 $0.98 $0.74 - $4.34 $37.2M 39.4M 474K -$0.41

Geninus Financials Summary

As of 30-Jun-2026, Geninus has a trailing 12-month revenue of $7.77M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 49,747 77,471 26,598 51,763
Revenue 7,771 7,366 4,731 5,329
EBITDA (11,626) (9,703) (7,184) (6,101)
Net Income (14,026) (12,208) (8,995) (7,407)
Total Assets 35,167 27,326 22,464 31,448
Total Debt 4,975 6,341 4,144 1,383
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Geninus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Geninus‘s full profile, request access.

Request a free trial

Geninus Patents

Geninus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026164346-A1 Method for generating a cell type annotation image, image processing device, and analysis device Pending 31-Jan-2025
WO-2026146685-A1 Composition for diagnosing prostate cancer using methylation level of cpg regions and use thereof Pending 02-Jan-2025
JP-2025076278-A Colorectal cancer diagnostic composition using cpg region methylation levels, and uses thereof Active 31-Oct-2023
WO-2025095485-A1 Composition for diagnosing colorectal cancer using methylation level of cpg site and use thereof Inactive 31-Oct-2023
US-20260245654-A1 Method and device for estimating binding between peptide and t cell receptor Pending 24-Jun-2022 G16B15/30
To view Geninus’s complete patent history, request access »

Geninus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geninus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Geninus‘s full profile, request access.

Request a free trial

Geninus ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Geninus’s complete esg history, request access »

Geninus FAQs

  • When was Geninus founded?

    Geninus was founded in 2017.

  • Where is Geninus headquartered?

    Geninus is headquartered in Songpa, South Korea.

  • What is the size of Geninus?

    Geninus has 63 total employees.

  • What industry is Geninus in?

    Geninus’s primary industry is Laboratory Services (Healthcare).

  • Is Geninus a private or public company?

    Geninus is a Public company.

  • What is Geninus’s stock symbol?

    The ticker symbol for Geninus is 389030.

  • What is the current stock price of Geninus?

    As of 19-Nov-2026 the stock price of Geninus is $0.94.

  • What is the current market cap of Geninus?

    The current market capitalization of Geninus is $37.2M.

  • What is Geninus’s current revenue?

    The trailing twelve month revenue for Geninus is $7.77M.

  • What is Geninus’s annual earnings per share (EPS)?

    Geninus’s EPS for 12 months was -$0.41.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process